# Base5 Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/base5-genomics

- Industry: Biotechnology
- Headquarters: Mountain View, US
- Website: www.b5genomics.com
- Total disclosed funding: $1.1M
- Latest round: Seed (May 22, 2020)
- Investors on record: 1

## About

Base5 Genomics, Inc. is a biotech firm specializing in advanced genomic analysis through its proprietary Benthic Analysis Platform, aimed at enhancing the accuracy and efficiency of genomic data interpretation for researchers and healthcare professionals.Founded in 2018 and headquartered in Mountain View, US, Base5 Genomics, Inc. focuses on advanced genomic analysis. The company raised USD 1.05 mn in a Seed funding round on May 22, 2020, led by TBA Network, bringing its total amount raised to USD 1.05 mn and its current valuation to USD 5.25 mn. The CEO, Solomon Endlich, has a background in biotech and has previously founded other companies in the sector.Base5 Genomics specializes in advanced genomic analysis through its core offering, the Benthic Analysis Platform. This platform transforms complex genomic regions, such as HLA, KIR, and polymorphic pharmacogenes, into high-confidence, actionable genomic calls. It utilizes various genomic input types—from microarray to short-read and long-read sequencing—to deliver precise, high-resolution genotyping and variant calls across various immune genes. The platform is targeted toward genomic researchers and clinical laboratories, primarily within North America and Europe, addressing the demand for advanced genomic analysis tools.Base5 Genomics generates revenue through the direct sales of its Benthic Analysis Platform and associated services to research institutions and clinical laboratories. The company offers subscription plans for its software, providing clients ongoing access to genomic analysis tools and support services. Revenue is largely derived from partnerships with academic and clinical entities that utilize the platform for high-resolution HLA typing and comprehensive gene coverage across the HLA locus. The pricing structure reflects the value of the platform's analytical capabilities, consistently delivering superior results compared to traditional methods.Following the recent Seed funding round of USD 1.05 mn in May 2020, Base5 Genomics plans to enhance its Benthic Analysis Platform with new features aimed at further improving genomic analysis capabilities. The company is also exploring expansion into European markets, with plans to establish a stronger presence by 2023. The funding will be utilized to support product development and market entry strategies.

## Funding rounds

- Seed, May 22, 2020, $1.1M — TBA Network

## Investors

- TBA Network (https://capitalatlas.ai/funds/tba-network) — Seed